CBG Group plc
Biographical Details of Directors
Laurie Turnbull, Non-Executive Chairman
Laurie, 58, educated in Glasgow, has a wealth of experience in a senior capacity in both public and private companies. First appointed to a plc board when he was 29 he has enjoyed a career as a CEO principally in manufacturing. For over 10 years he was CEO of Texas Group Plc where he was active in numerous acquisitions and flotations. This Manchester based venture capital company was instrumental in the formation and development of CBG in the years prior to its flotation in November 2003. He is also Non-Executive Chairman of Texas Holdings Limited, Executive Chairman of Source Bioscience Plc and Non-Executive Chairman of PenMc plc. He is responsible for chairing the Remuneration Committee and is a member of the Audit Committee.
Michael Askew, Group Managing Director
Mike is 47 and started his career with Sun Alliance in 1981. Initially concentrating on financial services he eventually set up a financial services division for an independent broker before expanding his role to business development across all sectors of the industry and being appointed managing director of the financial services division of that company. Together with Martin Lewis, he joined CBG in January 2001 as a founding director and is responsible for customer satisfaction and business development.
Martyn Hughes, Group Finance Director/Company Secretary
Martyn, 40, before moving into industry spent his first seven years in private practice including four years with Grant Thornton , principally engaged in auditing. He joined CBG in 2001 as part of the initial management team and was appointed to the Board on 8 October 2007. He is currently Company Secretary and a member of the acquisition team responsible for due diligence and integration. Martyn is also a Fellow of the Chartered Institute of Management Accountants.
Martin Lewis, Technical
Martin is 53 and his involvement in the insurance industry commenced with his role at Prudential as an account manager in 1973. He has held a number of senior positions in the industry including managing customer services, sales and marketing strategy, and the account management team. Martin was instrumental in founding CBG in January 2001 and is responsible for marketing, CBG's Southern operations, investor relations and is a member of the acquisition team.
Stephen Darcy, Insurance Broking Operations
Stephen, 51, joined the Board on 22 February 2006. He was the vendor of the Swinburne James companies which he established in 1994 and built over the years to be come one of the largest privately owned brokerages in the North West. Stephen has extensive knowledge of the insurance industry and is a skilled practitioner who has acted as an expert witness in industry litigation. He is Managing Director of CBG Insurance Brokers Limited.
Stuart Mollekin, Executive
Stuart, 48, has occupied senior financial positions in a number of private and public companies over the last twenty years, principally in the manufacturing sector. He spent the first 18 years of his career with Perkins Engines and, aged 27, was appointed Finance Director of the French operations of Perkins in Paris. He was Group Finance Director at L. Gardner Group PLC until early 2001 after which he was Group Finance Director of Direct Message plc and then Executive Director of Direct Message Group Limited. He is also Finance Director of Noble Investments (UK) plc and PenMc plc.
David Worsley, Non-Executive Director and Chair of Audit Committee
David is 61 and joined the Company in 2003, as Executive Chairman, from Texas Holdings Limited, the venture capital partner responsible for the initial investment in CBG. He is responsible for chairing the Audit Committee and is a member of the Remuneration Committee.
Robin Slinger, Non Executive Director
Robin is 54 and was a director of corporate banking for the National Westminster Bank plc until his retirement in 2004. He joined the board in October 2004 and took over the chair of the Remuneration Committee and was a member of the Audit Committee. He became the Chief Executive of the Group in August 2006. He has since stepped down as Deputy Chairman but continues to provide valuable skills and experience to the Board as a Non-Executive Director. He is also a non-executive director of Source Bioscience Plc.
